- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05778916
5 Year Radiological and Clinical Results From Patients Operated for Hallux Valgus Deformity.
March 20, 2023 updated by: Ostfold Hospital Trust
Radiological Outcome vs.Patient Reported Clinical Outcome 5 Years Post Hallux Valgus Surgery
Retrospective study of patients operated for hallux valgus deformity at our hospital (ostfold hospital trust) 5 years ago.
Patients will be clinically examined, a weighted radiograph of the foot (traditional and newer parameters will be evaluated) and patient reported outcome measures (PROM) scores will be collected.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
210
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Boel Mikaela Sofie E Hamre
- Phone Number: 41273586
- Email: mikaela.engaras@gmail.com
Study Contact Backup
- Name: Marius Molund
- Phone Number: 90093988
- Email: marius.molund@so-hf.no
Study Locations
-
-
Østfold
-
Sarpsborg, Østfold, Norway, 1714
- Østfold Hospital Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Norwegian speaking men and women operated for hallux valgus deformity at Ostfold hospital trust in the years 2016-2018.
Description
Inclusion Criteria:
- All patients (18-80 years at time of surgery) operated for hallux valgus deformity at ostfold hospital trust 2016-2018
Exclusion Criteria:
- Not able to speak/write/read norwegian language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical 5 year outcome
Time Frame: Data collection during 2023, completion during 2024
|
Clinical (Manchester-oxford Foot Questionnaire (MOxFQ)
|
Data collection during 2023, completion during 2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical VAS 5 year outcome
Time Frame: Data collection during 2023, completion during 2024
|
Visual analogue scale (VAS 0-10)
|
Data collection during 2023, completion during 2024
|
Clinical Likert scale 5 year outcome
Time Frame: Data collection during 2023, completion during 2024
|
Likert scale
|
Data collection during 2023, completion during 2024
|
Radiological outcomes
Time Frame: Until 2024
|
Measurement of correction
|
Until 2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Marius Molund, MD, phd, Ostfold Hospital Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 12, 2023
Primary Completion (Anticipated)
April 12, 2024
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
November 28, 2022
First Submitted That Met QC Criteria
March 20, 2023
First Posted (Actual)
March 22, 2023
Study Record Updates
Last Update Posted (Actual)
March 22, 2023
Last Update Submitted That Met QC Criteria
March 20, 2023
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ostfold Hospital Trust
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hallux Valgus
-
Arthrex GmbHTerminated
-
Catherine Vandepitte, M.D.Pacira Pharmaceuticals, IncCompleted
-
Asklepieion Voulas General HospitalMaria Tileli; Chryssoula StaikouUnknown
-
Dr.Gerhard KaufmannMedical University InnsbruckCompletedHallux Valgus and BunionAustria
-
Chinese University of Hong KongCompletedHallux Valgus | Hallux Valgus and BunionHong Kong
-
Hospital Mutua de TerrassaUnknownHallux Valgus and Bunion (Disorder)Spain
-
Assiut UniversityNot yet recruitingHallux Valgus and Bunion
-
Cali Pharmaceuticals LLCCompletedHallux Valgus and BunionUnited States
-
Fundación Universidad Católica de Valencia San...RecruitingHallux Valgus and BunionSpain
-
Dr.Gerhard KaufmannMedical University InnsbruckCompletedHallux Valgus | Hallux Valgus InterphalangeusAustria
Clinical Trials on 5 year follow up on patients operated for hallux valgus deformity
-
Centre Hospitalier Universitaire de NīmesInstitute of Human Genetics, MontpellierActive, not recruitingCovid-19 | SARS-CoV-2France
-
Zagazig UniversityCompletedAtypical Endometrial HyperplasiaEgypt
-
Nantes University HospitalCompletedPatients Receiving Animal-derived Bioprosthetic Heart ValvesFrance, Canada, Italy, Spain